Target intelligence / Profile preview

Hemozoin (Ferriprotoporphyrin IX aggregates) (HZ)

Target
HZ
Molecular classification
Other
01

Overview

Hemozoin is a dark-brown biocrystal formed by Plasmodium parasites within their acidic food vacuole as an essential mechanism for detoxifying free heme (Hempelmann, 2007, Parasitology Research). During the intraerythrocytic stage of malaria, the parasite digests host hemoglobin to obtain amino acids, a process that releases large quantities of toxic ferriprotoporphyrin IX (Fe(III)PPIX) (Egan et al., 2002, Journal of Inorganic Biochemistry). To prevent the oxidative damage and membrane disruption caused by free heme, the parasite sequesters it into insoluble, chemically inert hemozoin crystals. This biocrystallization process is the primary target for several classes of antimalarial drugs, most notably the quinolines such as chloroquine and quinine, which bind to the heme monomers or the crystal facets to inhibit further growth (Sullivan et al., 1996, Science). The resulting accumulation of toxic free heme leads to the generation of reactive oxygen species and the eventual lysis of the parasite (Pagola et al., 2000, Nature). Because hemozoin formation is a unique metabolic pathway not found in human physiology, it remains one of the most effective and selective targets for antimalarial chemotherapy, despite the emergence of resistance (Egan, 2008, Journal of Chemical Biology).

Other names
Malaria pigmentFerriprotoporphyrin IX aggregatesBeta-hematinHeme aggregatesHeme crystals
02

Mechanism of action

Inhibition of hemozoin biocrystallization, leading to the accumulation of toxic free ferriprotoporphyrin IX which causes oxidative damage and parasite lysis (Sullivan et al., 1996, Science).

03

Biological functions

Other
04

Disease associations

Infection
05

Safety considerations

Development of drug resistance via the Plasmodium falciparum chloroquine resistance transporter (PfCRT)Retinal toxicity associated with long-term quinoline useCardiotoxicity and QT prolongation
06

Interacting drugs

Chloroquine

6 more in the full profile.

07

Biomarkers

Hemozoin concentration in monocytesMagneto-optical detection of hemozoinParasitemia levels

Beyond the preview

Go deeper on Hemozoin (Ferriprotoporphyrin IX aggregates) (HZ).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemozoin (Ferriprotoporphyrin IX aggregates) (HZ).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call